Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Neural mechanisms of disease pathology and cognition in young-onset Alzheimer’s Disease variants

Seda Sacu, Catherine F. Slattery, Karl J. Friston, Ross W. Paterson, Alexander J.M. Foulkes, Keir Yong, Sebastian Crutch, Jonathan M. Schott, Adeel Razi
doi: https://doi.org/10.1101/2024.03.11.24304042
Seda Sacu
1Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine F. Slattery
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl J. Friston
3Wellcome Centre for Human Neuroimaging, Institute of Neurology, University College London London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ross W. Paterson
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander J.M. Foulkes
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keir Yong
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Crutch
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan M. Schott
2Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adeel Razi
3Wellcome Centre for Human Neuroimaging, Institute of Neurology, University College London London, United Kingdom
4Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Australia
5CIFAR Azrieli Global Scholars Program, CIFAR, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: adeel.razi{at}monash.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Late-onset Alzheimer’s disease is consistently associated with alterations in the default-mode network (DMN)—a large-scale brain network associated with self-related processing and memory. However, the functional organization of DMN is far less clear in young-onset Alzheimer’s disease (YOAD). We assessed resting-state DMN effective connectivity in two common YOAD variants (i.e., amnestic variant (n = 26) and posterior cortical atrophy (n = 13) and healthy participants (n=24) to identify disease- and variant-specific connectivity differences using spectral dynamic causal modelling. Patients with the amnestic variant showed increased connectivity from prefrontal cortex to posterior DMN nodes relative to healthy controls, whereas patients with posterior cortical atrophy exhibited decreased posterior DMN connectivity. Right hippocampus connectivity differentiated the two patient groups. Furthermore, disease-related connectivity alterations were also predictive of group membership and cognitive performance. These findings suggest that resting-state DMN effective connectivity provides a new understanding of neural mechanisms underlying the disease pathology and cognition in YOAD.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The YOAD study was funded by Alzheimer's Research UK through a generous donation from Iceland Foods. AR and KJF are affiliated with The Wellcome Centre for Human Neuroimaging, supported by core funding from Wellcome [203147/Z/16/Z]. AR is a CIFAR Azrieli Global Scholar in the Brain, Mind & Consciousness Program. JMS acknowledges the support ofthe National Institute for Health Research University College London Hospitals Biomedical Research Centre, Wolfson Foundation, Alzheimer's Research UK, Brain Research UK, Weston Brain Institute, Medical Research Council, British Heart Foundation, UK Dementia Research Institute and Alzheimer's Association. A.R. is funded by the Australian Research Council (Ref: DP200100757) and the Australian National Health and Medical Research Council (Investigator Grant 1194910). RWP acknowledges support from the National Institute for Health Research University College London Hospitals Biomedical Research Centre, the Alzheimer's Association. SC acknowledges the support of the Economic and Social Research Council and National Institute for Health Research (ESRC/NIHR ES/L001810/1). K. Y. is an Etherington PCA Senior Research Fellow and is funded by the Alzheimer's Society, grant number 453 (ASJF/18/003).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the National Hospital for Neurology and Neurosurgery Research Ethics Committee. All participants provided written informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • We have added new analyses examining associations between effective connectivity parameters and cognitive performance. The new version has more focus on cognition compared to the previous version. The main analysis and results stayed the same.

Data Availability

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 23, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Neural mechanisms of disease pathology and cognition in young-onset Alzheimer’s Disease variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Neural mechanisms of disease pathology and cognition in young-onset Alzheimer’s Disease variants
Seda Sacu, Catherine F. Slattery, Karl J. Friston, Ross W. Paterson, Alexander J.M. Foulkes, Keir Yong, Sebastian Crutch, Jonathan M. Schott, Adeel Razi
medRxiv 2024.03.11.24304042; doi: https://doi.org/10.1101/2024.03.11.24304042
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Neural mechanisms of disease pathology and cognition in young-onset Alzheimer’s Disease variants
Seda Sacu, Catherine F. Slattery, Karl J. Friston, Ross W. Paterson, Alexander J.M. Foulkes, Keir Yong, Sebastian Crutch, Jonathan M. Schott, Adeel Razi
medRxiv 2024.03.11.24304042; doi: https://doi.org/10.1101/2024.03.11.24304042

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3312)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5174)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3283)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1022)
  • Infectious Diseases (except HIV/AIDS) (14650)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4949)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1018)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)